<SubstanceDefinition xmlns="http://hl7.org/fhir"><id value="trastuzumab"/><identifier><system value="http://example.europa.eu/fhir/SMSId"/><value value="TRAS9123H"/></identifier><status><coding><system value="http://hl7.org/fhir/publication-status"/><code value="active"/><display value="Active"/></coding></status><classification><coding><system value="http://example.europa.eu/fhir/SubstanceType"/><code value="protein"/><display value="Protein"/></coding></classification><domain><coding><system value="http://example.europa.eu/fhir/Domain"/><code value="human"/><display value="Human use"/></coding></domain><description value="Trastuzumab — humanised IgG1 monoclonal antibody targeting the human epidermal growth factor receptor 2 (HER2/ErbB2). Variable regions derived from murine antibody 4D5, grafted onto human IgG1 framework. Produced in Chinese hamster ovary (CHO) cells."/><code><code><coding><system value="http://example.europa.eu/fhir/Substance"/><code value="TRAS9123H"/></coding></code></code><name><name value="Trastuzumab"/><preferred value="true"/><language><coding><system value="urn:ietf:bcp:47"/><code value="en"/><display value="English"/></coding></language><official><authority><coding><system value="http://hl7.org/fhir/substance-name-authority"/><code value="INN"/><display value="INN"/></coding></authority><status><coding><system value="http://hl7.org/fhir/publication-status"/><code value="active"/><display value="Active"/></coding></status></official></name><name><name value="Herceptin"/><preferred value="false"/></name><protein><sequenceType><coding><system value="http://hl7.org/fhir/substance-sequence-type"/><code value="complete"/><display value="Complete"/></coding></sequenceType><numberOfSubunits value="2"/><disulfideLinkage value="HC22-HC96; HC144-HC200; HC222-LC214; HC228-HC228'; HC231-HC231'; HC265-HC325; HC371-HC429"/><subunit><subunit value="1"/><sequence value="EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS..."/><length value="450"/><nTerminalModification><concept><coding><system value="http://example.europa.eu/fhir/Modification"/><code value="pyroglutamate"/><display value="Pyroglutamic acid (pE)"/></coding></concept></nTerminalModification><cTerminalModification><concept><coding><system value="http://example.europa.eu/fhir/Modification"/><code value="lysine-clipped"/><display value="C-terminal lysine clipping"/></coding></concept></cTerminalModification></subunit><subunit><subunit value="2"/><sequence value="DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK..."/><length value="214"/></subunit><gene><sequenceOrigin><coding><system value="http://hl7.org/fhir/gene-sequence-origin"/><code value="humanised-mouse"/><display value="Humanised mouse"/></coding></sequenceOrigin><gene><concept><coding><system value="http://www.genenames.org"/><code value="IGHG1"/><display value="Immunoglobulin heavy constant gamma 1"/></coding></concept></gene></gene></protein><relationship><substanceDefinitionReference><reference value="SubstanceDefinition/her2"/><display value="Receptor tyrosine-protein kinase erbB-2 (HER2)"/></substanceDefinitionReference><type><coding><system value="http://hl7.org/fhir/substance-relationship-type"/><code value="TherapeuticTarget"/><display value="Therapeutic target"/></coding></type><interaction><coding><system value="http://hl7.org/fhir/substance-interaction-type"/><code value="binding"/><display value="Binding"/></coding></interaction><measurementType><coding><system value="http://hl7.org/fhir/substance-measurement-type"/><code value="kd"/><display value="Kd"/></coding></measurementType><amountQuantity><value value="0.1"/><unit value="nM"/><system value="http://unitsofmeasure.org"/><code value="nmol/L"/></amountQuantity></relationship></SubstanceDefinition>